The office of Oklahoma Attorney General John O’Connor said it “finds no legal basis for a state medical licensure board to discipline a licensed physician” for using their judgment and prescribing FDA-approved drugs for the off-label — when a drug approved for a specific disease or condition is prescribed for something else — purpose of treating COVID-19.
“I stand behind doctors who believe it is in their patients’ best interests to receive ivermectin and hydroxychloroquine,” Mr. O’Connor said. “Our healthcare professionals should have every tool available to combat COVID-19. Public safety demands this. Physicians who prescribe medications and follow the law should not fear disciplinary action for prescribing such drugs.”
The FDA has not approved ivermectin or hydroxychloroquine for prevention or treatment of COVID-19. The two treatments have made headlines in recent months as some hospitals have fired or suspended physicians for prescribing or promoting the treatments for COVID-19.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
